UNLOXCYT (cosibelimab-ipdl) is indicated for the treatment of adults with metastatic cutaneous squamous cell carcinoma (“cSCC”) or locally advanced cSCC who are not candidates for curative surgery or ...
Rethink, the leading SaaS software and solutions provider in behavioral health, today announced that it has appointed Paul Bogonis as chief financial officer and Ewan Auguste as chief marketing ...